List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.3. Antifungal medicines |
Others observations: For treatment of chronic pulmonary aspergillosis and acute invasive aspergillosis. |
PAHO Strategic Fund Medicine List | 2.5. Antifungal | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.3. Antifungal medicines |
Others observations: For treatment of chronic pulmonary aspergillosis and acute invasive aspergillosis. |
PAHO Strategic Fund Medicine List | 2.5. Antifungal | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.3. Antifungal medicines |
Others observations: For treatment of chronic pulmonary aspergillosis and acute invasive aspergillosis. |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.3. Antifungal medicines |
Others observations: For treatment of chronic pulmonary aspergillosis and acute invasive aspergillosis. |
PAHO Strategic Fund Medicine List | 2.5. Antifungal | No observations |